Three AI-Designed Drug Candidates Enter Phase 1 Clinical Trials

Isomorphic Labs, Recursion Pharmaceuticals, and Insilico Medicine each advance AI-designed drug candidates into Phase 1 clinical trials, marking a significant milestone for AI-driven drug discovery.